Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Emerge Weight Loss vs NowPatient

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.6

Emerge Weight Loss

Best for patients committed to tirzepatide as their drug of choice

Starting at $299/mo

CompoundedTirzepatideTelehealthPhysician supervised
Visit Emerge Weight Loss
7.1

NowPatient

Best for early adopters who want Foundayo via a one-stop telehealth platform

Starting at $199/mo

FoundayoTelehealthBrand Name
Visit NowPatient

Side-by-Side Comparison

FeatureEmerge Weight LossNowPatient
Overall Score7.6/107.1/10
Starting Price$299/mo$199/mo
Customer Rating
Features4 features3 features
States Available5051
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Emerge Weight Loss

Pros

  • Tirzepatide-focused (largest effect-size compounded GLP-1)
  • Wide dose range available
  • Physician-supervised telemedicine model

Cons

  • No semaglutide option — limits flexibility if tirzepatide tolerability is poor
  • Less brand recognition than Henry Meds, Mochi, or SkinnyRx

NowPatient

Pros

  • Confirmed early Foundayo channel (April 2026 rollout)
  • Daily oral pill — no needles, no refrigeration
  • Telehealth consultation included

Cons

  • Pricing tier not yet publicly verified — confirm directly with the provider
  • State-by-state availability still being phased in
  • Lower mean weight loss vs injectable GLP-1s (~11.1% vs 14.9% Wegovy and 20.9% Zepbound at labeled max)

Our Verdict

Winner: Emerge Weight LossScore: 7.6/10

Emerge Weight Loss edges out NowPatient with a higher overall score of 7.6/10 and is particularly strong for patients committed to tirzepatide as their drug of choice. NowPatient remains a solid alternative, especially if you're looking for early adopters who want Foundayo via a one-stop telehealth platform.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.